Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of Endothelial Cells via Induction of SOD2 and SIRT1

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Miyashita, Hiroki ^a   Watanabe, Tatsuaki ^a   Hayashi, Hideki ^a,b   Suzuki, Yasuhiro ^a   Nakamura, Takanobu ^a   Ito, Soichi ^a   Ono, Manabu ^a   Hoshikawa, Yasushi ^a   Okada, Yoshinori ^a   Kondo, Takashi ^a   Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; HUR PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; PARAQUAT; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; UNCLASSIFIED DRUG; VASOHIBIN 1;

ACUTE LUNG INJURY; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DEATH; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SYNTHESIS; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM; SENESCENCE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BASE SEQUENCE; CELL AGING; CELL CYCLE PROTEINS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; ENZYME INDUCTION; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIRTUIN 1; STRESS, PHYSIOLOGICAL; SUPEROXIDE DISMUTASE;

EID: 84867322533     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046459     Document Type: Article

References (48)

1. Phng LK, Gerhardt H, (2009) Angiogenesis: a team effort coordinated by notch. Dev Cell 16: 196-208.
2. Watanabe K, Hasegawa Y, Yamashita H, Shimizu K, Ding Y, et al. (2004) Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest 114: 898-907.
3. Kimura H, Miyashita H, Suzuki Y, Kobayashi M, Watanabe K, et al. (2009) Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood 113: 4810-4818.
4. Andreassi MG, (2009) Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Mutat Res 667: 35-43.
5. Erusalimsky JD, Kurz DJ, (2005) Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol 40: 634-642.
6. Minamino T, Komuro I, (2008) Role of telomeres in vascular senescence. Front Biosci 13: 2971-2979.
7. O'Riordan E, Mendelev N, Patschan S, Patschan D, Eskander J, et al. (2007) Chronic NOS inhibition actuates endothelial-mesenchymal transformation. Am J Physiol Heart Circ Physiol 292: H285-294.
8. Miyashita H, Suzuki H, Ohkuchi A, Sato Y, (2011) Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells. Pharmaceuticals 4: 782-793.
9. Namba K, Abe M, Saito S, Satake M, Ohmoto T, et al. (2000) Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31. Oncogene 19: 106-114.
10. Hosaka T, Kimura H, Heishi T, Suzuki Y, Miyashita H, et al. (2009) Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis. Am J Pathol 175: 430-439.
11. Jang YC, Perez VI, Song W, Lustgarten MS, Salmon AB, et al. (2009) Overexpression of Mn superoxide dismutase does not increase life span in mice. J Gerontol A Biol Sci Med Sci 64: 1114-1125.
12. Yamashita H, Abe M, Watanabe K, Shimizu K, Moriya T, et al. (2006) Vasohibin prevents arterial neointimal formation through angiogenesis inhibition. Biochem Biophys Res Commun 345: 919-925.
13. DuPage M, Dooley AL, Jacks T, (2009) Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 4: 1064-1072.
14. Zhan H, Suzuki T, Aizawa K, Miyagawa K, Nagai R, (2010) Ataxia telangiectasia mutated (ATM)-mediated DNA damage response in oxidative stress-induced vascular endothelial cell senescence. J Biol Chem 285: 29662-29670.
15. Rajawat YS, Hilioti Z, Bossis I, (2009) Aging: central role for autophagy and the lysosomal degradative system. Ageing Res Rev 8: 199-213.
16. Suzuki Y, Kobayashi M, Miyashita H, Ohta H, Sonoda H, et al. (2010) Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion. J Cell Sci 123: 3094-3101.
17. Hinman MN, Lou H, (2008) Diverse molecular functions of Hu proteins. Cell Mol Life Sci 65: 3168-3181.
18. Abdelmohsen K, Lal A, Kim HH, Gorospe M, (2007) Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6: 1288-1292.
19. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, et al. (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130: 691-703.
20. Bertram C, Hass R, (2008) Cellular responses to reactive oxygen species-induced DNA damage and aging. Biol Chem 389: 211-220.
21. Potente M, Dimmeler S, (2008) Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 7: 2117-22.
22. Gorospe M, de Cabo R, (2008) AsSIRTing the DNA damage response. Trends Cell Biol 18: 77-83.
23. Tomita M, Okuyama T, Katsuyama H, Miura Y, Nishimura Y, et al. (2007) Mouse model of paraquat-poisoned lungs and its gene expression profile. Toxicology 231: 200-209.
24. Gurevich F, Perazella MA, (2009) Renal effects of anti-angiogenesis therapy: update for the internist. Am J Med 122: 322-328.
25. Heishi T, Hosaka T, Suzuki Y, Miyashita H, Oike Y, et al. (2010) Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis. Am J Pathol 176: 1950-1958.
26. Saito D, Maeshima Y, Nasu T, Yamasaki H, Tanabe K, et al. (2011) Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis. Am J Physiol Renal Physiol 300: F873-886.
27. Shimizu K, Watanabe K, Yamashita H, Abe M, Yoshimatsu H, et al. (2005) Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells. Biochem Biophys Res Commun 327: 700-706.
28. Ushio-Fukai M, Alexander RW, (2004) Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264: 85-97.
29. Fukai T, Ushio-Fukai M, (2011) Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15: 1583-1606.
30. Suzuki K, Tatsumi H, Satoh S, Senda T, Nakata T, et al. (1993) Manganese-superoxide dismutase in endothelial cells: localization and mechanism of induction. Am J Physiol 265: H1173-1178.
31. Didion SP, Faraci FM, (2005) Ceramide-induced impairment of endothelial function is prevented by CuZn superoxide dismutase overexpression. Arterioscler Thromb Vasc Biol 25: 90-95.
32. Finkel T, Deng CX, Mostoslavsky R, (2009) Recent progress in the biology and physiology of sirtuins. Nature 460: 587-591.
33. Orimo M, Minamino T, Miyauchi H, Tateno K, Okada S, et al. (2009) Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol 29: 889-894.
34. Stein S, Lohmann C, Schafer N, Hofmann J, Rohrer L, et al. (2010) SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 31: 2301-2309.
35. Takemura A, Iijima K, Ota H, Son BK, Ito Y, et al. (2011) Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 31: 2054-2062.
36. Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, et al. (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 80: 191-199.
37. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, et al. (2007) SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 21: 2644-2658.
38. Ono M, (2008) Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99: 1501-1506.
39. Naik E, Dixit VM, (2011) Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 208: 417-420.
40. Shibuya T, Watanabe K, Yamashita H, Shimizu K, Miyashita H, et al. (2006) Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Arterioscler Thromb Vasc Biol 26: 1051-1057.
41. Chen J, Patschan S, Goligorsky MS, (2008) Stress-induced premature senescence of endothelial cells. J Nephrol 21: 337-344.
42. Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, et al. (2009) Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. Diabetes 58: 2365-2375.
43. Han MK, (2011) Update in chronic obstructive pulmonary disease in 2010. Am J Respir Crit Care Med 183: 1311-1315.
44. Jerkic M, Kabir MG, Davies A, Yu LX, McIntyre BA, et al. (2011) Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress. Cardiovasc Res 92: 375-384.
45. de Perrot M, Liu M, Waddell TK, Keshavjee S, (2003) Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167: 490-511.
46. Nakamaru Y, Vuppusetty C, Wada H, Milne JC, Ito M, et al. (2009) A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J 23: 2810-2819.
47. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I, (2008) SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 861-870.
48. Siedlinski M, van Diemen CC, Postma DS, Vonk JM, Boezen HM, (2009) Superoxide dismutases, lung function and bronchial responsiveness in a general population. Eur Respir J 33: 986-992.